Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 11/25/11 | 8-K | Current report filing |
|
3 | |
| 11/14/11 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
39 |
| 11/10/11 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
5 | |
| 11/10/11 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
8 | |
| 09/15/11 | 8-K | Current report filing |
|
5 | |
| 08/19/11 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
1 | |
| 08/19/11 | 8-K | Current report filing |
|
4 | |
| 08/18/11 | 8-K | Current report filing |
|
4 | |
| 08/15/11 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
36 |
| 07/27/11 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
